Home
About
Overview
Sharing Data
ORCID
Help
History (74)
MicroRNA-378 controls classical brown fat expansion to counteract obesity.
The role of clinical research nurses in minority recruitment to cancer clinical trials.
Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.
Multiple Chronic Conditions and Psychosocial Limitations in Patients Hospitalized with an Acute Coronary Syndrome.
Novel drug combinations for the management of relapsed/refractory multiple myeloma.
See All 74 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel drug combinations for the management of relapsed/refractory multiple myeloma.
Usmani SZ, Lonial S. Novel drug combinations for the management of relapsed/refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S71-7.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Disease Management
Disease Progression
Histone Deacetylase Inhibitors
Humans
Multiple Myeloma
Oligopeptides
Proteasome Inhibitors
Recurrence
Thalidomide
authors with profiles
Saad Usmani MD